Global Two-Way Radio Communications Provider Hytera Sues Motorola Solutions for Patent Infringement
Shenzhen, China-based Hytera Communications Corporation Limited, the world's leading provider of innovative professional mobile radio (PMR) solutions, today filed a lawsuit against Chicago, Ill.-based Motorola Solutions, Inc. in federal district court in Cleveland, Ohio, charging that Motorola Solutions is infringing Hytera's U.S. Patent No. 9,183,846, which covers its industry-leading sound adjustment control technology.
Hytera's '846 patent is its inventive method for adjusting sound volume in response to background or ambient noise, allowing a radio operator to hear and speak over it. The device obtains the current level of ambient noise, receives an instruction, and adjusts sound output. If ambient noise is high, the volume adjustment is greater at higher (treble) frequencies. Hytera's complaint asserts that Motorola Solutions unlawfully misappropriates Hytera’s patented technology for sound adjustment, incorporating it into its MOTOTRBO portable radios.
"Hytera has changed the landscape of the PMR business with its constant innovations, especially after its launch of a digital product line in 2010," said Tom Wineland, Director of Sales for Hytera Communications America (West), Inc. in Irvine, Calif. "Our patented sound adjustment functionality is one of the many innovations that Hytera has incorporated into our digital products, and users in markets around the world have embraced this feature."
Hytera's two-way radio communications equipment includes hand portables, mobiles, base stations, and dispatching and management software. Its products and solutions are used by commercial industries, such as energy companies and utilities, event organizers and producers, security and emergency management response teams, schools and other educational institutions, and public safety organizations. During use, personnel using Hytera's devices frequently move from quiet environments with little background noise to loud environments where machinery, engines, crowd noise, sirens, or other noises make it difficult to hear.
As embodied in the '846 patent, Hytera's sound adjustment capability is a key technological advance in PMR speaker design that is critical in a variety of noisy situations. "Our users—police and emergency responders, stadium and event managers, and commercial users—benefit greatly from this capability in our devices," adds Wineland.
"Motorola Solutions is infringing Hytera's sound adjustment control patent," said Andrew Yuan, Hytera's President of North and South America. "Hytera is a leader in innovative technologies, and an adamant advocate of intellectual property rights. We will look to enforce our patents in court in the U.S. and worldwide."
Hytera invests up to 15 percent of annual revenue in research and development, notes Yuan, including in open standard technologies, and is continually developing customized solutions that couple versatile LTE broadband for video and data transmission with traditional PMR narrow-band two-way voice communications. Hytera is one of the few companies worldwide that offers market-leading TETRA, DMR, and PDT technologies, and that offers products and solutions under all mainstream digital protocols. Hytera currently holds 480 issued patents, including 269 patents for digital products (DMR, TETRA, and PDT).
Hytera is the second-largest professional mobile radio communications solutions provider in the world, and the world’s fastest-growing. Hytera also is the world’s #1 DMR trunking provider. Hytera has partnered with companies in the U.S. since 2000, and established its first U.S. subsidiary, Hytera America, Inc., in 2004. Hytera established Hytera Communications America (West), Inc., in 2016 and opened research and equipment servicing facilities in the Chicago area this year.
Hytera further claims that Motorola has been and still is indirectly infringing Hytera's ‘846 Patent by actively inducing direct infringement by other persons who use products that embody one or more of the claims of the patent while Motorola had knowledge of the patent, knew or should have known that its actions would induce direct infringement by others, and intended that its actions would induce such direct infringement. Hytera is also alleging contributory infringement. Hytera is seeking damages and will pursue further relief as appropriate.
Hytera filed its lawsuit in the U.S. District Court for the Northern District of Ohio, in Cleveland, Ohio. The patent-at-issue is U.S. Patent No. 9,183,846 (“the ‘846 Patent”) titled “Method and Device for Adaptively Adjusting Sound Effect.” Hytera is represented in this action by Todd Tucker of Cleveland, Ohio-based law firm Calfee, Halter & Griswold LLP.
About Hytera Communications Corporation Limited
Founded in Shenzhen, China in 1993, Hytera Communications Corporation Limited is a closely-held privately-run company listed on the Shenzhen Stock Exchange (002583.SZ). With ten research and development centers around the world, Hytera is a leading global provider of innovative professional mobile radio (PMR) communications solutions to governmental organizations, public security institutions, and customers from other industries including transportation, oil and gas, and many others. Hytera aspires to leverage its technologies to improve organizational efficiency and make the world safer. Hytera's headquarters are at Hytera Tower, Shenzhen Hi-Tech Industrial Park North, Beihuan RD. 9108 Nanshan District, Shenzhen, P.R.C. In the U.S., the company has operations in Miramar, Fla., Irvine, Calif., and Chicago, Ill. More information is at www.hytera.com.
Hytera Communications Corporation Limited
For more than 50 years, Business Wire has been the global leader in press release distribution and regulatory disclosure.
Tilaa tiedotteet sähköpostiisi
Haluatko tietää asioista jo ennen kuin ne uutisoidaan? Kun tilaat tiedotteemme tältä julkaisijalta, saat ne sähköpostiisi yhtä aikaa suomalaisen median kanssa. Tilauksen voit halutessasi perua milloin tahansa.
Lue lisää julkaisijalta Business Wire
OTEZLA® (Apremilast) Phase III Data Showed Significant Improvements in Patients with Active Behçet’s Disease with Oral Ulcers18.2.2018 00:00 | Tiedote
Celgene Corporation (NASDAQ:CELG) today announced that data from the phase III RELIEF™ clinical trial of OTEZLA® (apremilast) in patients with active Behçet’s Disease with oral ulcers were presented in a late-breaking oral presentation at the 2018 American Academy of Dermatology (AAD) Annual Meeting. The results showed statistically significant reductions in oral ulcers with apremilast 30 mg twice daily (BID) versus placebo through week 12. OTEZLA (apremilast) is Celgene’s oral selective inhibitor of phosphodiesterase 4 (PDE4). Behçet’s Disease is a rare, chronic, multi-system inflammatory syndrome. Oral ulcers, the most common manifestation of Behçet’s Disease, can be disabling and have a substantial effect on quality of life. This study primarily evaluated the effect of apremilast on recurring oral ulcers in patients with active Behçet’s Disease who were previously treated with at least one topical or systemic medication. “Reducing oral ulcers, which are painful and can negatively im
CT-P13 (biosimilar infliximab) is comparable to reference infliximab and adalimumab in highly anticipated real-world study17.2.2018 11:00 | Tiedote
Twelve-month data from the Personalised Anti-TNF therapy in Crohn’s disease Study (PANTS) was presented at the 13th Congress of the European Crohn’s and Colitis Organisation (ECCO). The results indicate that the clinical effectiveness, safety and immunogenicity of Celltrion Healthcare’s CT-P13 (biosimilar infliximab) in patients with Crohn’s disease (CD) is comparable to those treated with reference infliximab as well as those treated with adalimumab.1 The UK-wide, three-year prospective observational study investigated primary non-response (PNR), loss of response (LOR) and adverse drug reactions (ADR) to infliximab (reference infliximab and CT-P13) and adalimumab in 1610 CD patients. The data show comparable efficacy between CT-P13, reference infliximab and adalimumab in relation to PNR, LOR and ADR rates. In addition, at week 54, the remission rate was 39.7%, 39.0% and 32.7% for reference infliximab, CT-P13 and adalimumab treated patients, respectively.1 The PANTS study investigates
Avanti Communications HYLAS 4 Satellite Arrives in French Guiana16.2.2018 21:26 | Tiedote
Avanti Communications Group plc (“Avanti”), a leading provider of satellite data communications services in Europe, the Middle East and Africa (“EMEA”), announces its HYLAS 4 satellite has arrived safely in French Guiana ahead of its March 2018 launch. This press release features multimedia. View the full release here: http://www.businesswire.com/news/home/20180216005586/en/ Avanti Communications HYLAS 4 Satellite Arrives in French Guiana (Photo: Business Wire) The spacecraft, built by Orbital ATK was packed and shipped at their Satellite Manufacturing Facility in Dulles, Virginia, United States and flown to French Guiana, where it was unloaded and will be taken to the Arianespace launch facilities in Kourou. HYLAS 4 uses the latest High Throughput Satellite technology, doubling Avanti's Ka-band capacity across EMEA. The latest addition to Avanti's HYLAS fleet will provide: Backhaul services for mobile network operators Wholesale broadband for ISPs Connectivity for governments (civil a
General Cable Corporation Stockholders Approve Acquisition By Prysmian Group16.2.2018 20:05 | Tiedote
General Cable Corporation (NYSE: BGC) today announced the voting results from the Company’s special meeting of stockholders held this morning. Stockholders of General Cable approved the Company’s previously announced acquisition by Prysmian Group (BIT: PRY) for $30.00 per share in cash. A total of 38,140,754 shares, representing approximately 75.34% of the total number of shares of common stock outstanding and approximately 99% of the total votes cast, were voted in favor of the merger. Subject to regulatory approvals and other customary closing conditions, the transaction is expected to close by the third quarter of 2018. About General Cable General Cable (NYSE:BGC), with headquarters in Highland Heights, Kentucky, is a global leader in the development, design, manufacture, marketing and distribution of aluminum, copper and fiber optic wire and cable products for the energy, communications, automotive, industrial, construction and specialty segments. General Cable is one of the larges
Systemic Sclerosis World Congress:Inspirational Patient Stories Reveal the Challenging Realities of Living with Devastating Rare Disease16.2.2018 12:03 | Tiedote
Boehringer Ingelheim today unveils a new phase of 'More Than Scleroderma: The Inside Story', and launches the new patient website www.morethanscleroderma.com. This press release features multimedia. View the full release here: http://www.businesswire.com/news/home/20180216005188/en/ Anna, 36, living with scleroderma (Photo: Business Wire) The global initiative highlights the importance of understanding the ‘inside story’ of each individual living with scleroderma, also known as systemic sclerosis. To coincide with the Systemic Sclerosis World Congress in Bordeaux, 15-17 February 2018, new and truly inspiring patient stories are revealed, reflecting the real-life, diverse and very moving journeys of people living with scleroderma across the world. The campaign will also be launched in the U.S. The new website www.morethanscleroderma.com features a powerful collection of photographs and video stories of people living with scleroderma across the world, revealing the life-changing impact o
Philip Morris International Recognized as a Global Top Employer for the Second Year in a Row16.2.2018 11:00 | Tiedote
Philip Morris International Inc. (PMI) (NYSE/Euronext Paris: PM) today is recognized for the second year in a row as a Global Top Employer. This year’s certification from the Top Employer Institute is awarded to PMI teams in 44 countries, a testament to the company’s consistency and excellence in offering an enriching and dynamic work environment, and exceptional development opportunities for employees across the globe. PMI has been recognized by the Top Employer Institute for six consecutive years. This year, PMI was awarded with five regional certifications in Europe, the Middle East, Africa and, for the first time, in North America and Latin America. Additionally, Indonesia was the first PMI affiliate to be certified in Asia. “It is a proud moment for all of us at PMI,” said Charles Bendotti, PMI Senior Vice President, People and Culture. “Our success as a company relies on the men and women who come to work every day with a passion to achieve, and a willingness to learn, grow, and
Uutishuoneessa voit lukea tiedotteitamme ja muuta julkaisemaamme materiaalia. Löydät sieltä niin yhteyshenkilöidemme tiedot kuin vapaasti julkaistavissa olevia kuvia ja videoita. Uutishuoneessa voit nähdä myös sosiaalisen median sisältöjä. Kaikki STT Infossa julkaistu materiaali on vapaasti median käytettävissä.Tutustu uutishuoneeseemme